Kent Mark D. purchased $198K of ALHC

Kent Mark D. (President - MSO) purchased 14,848 shares of Alignment Healthcare, Inc. (ALHC) at $13.31 ($0.20M total) on 2026-06-02.

Original reporting
SEC EDGAR · Kent Mark D.
Published Jun 2, 2026, 10:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 11:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALHC
Bullish
medium confidence
Mentioned
$ALHC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCBullishLow
01

Why it matters

The disclosure may slightly improve near-term sentiment and can be used as a supportive input for positioning, but it does not change the company’s fundamentals on its own.

02

Market read

A same-day insider open-market buy of ~14,848 shares at ~$13.31/share is a modest positive signal for ALHC sentiment.

03

What to watch

Check whether the officer has a history of buys/sells and whether there are concurrent corporate events (financing, guidance, contracts) not captured in this Form 4.

Relevance 7/10Novelty 6/10Timing: Filed same day as the open-market purchase (2026-06-02).

Background

This is an SEC Form 4 insider transaction disclosure for Alignment Healthcare, Inc., showing an officer/direct purchase.

Company-level read

Ticker impact

$ALHCBullishMedium confidence
Context

Alignment Healthcare officer Kent Mark purchased $197.6K of ALHC shares in an open-market transaction on 2026-06-02.

Expected impact

Likely limited/short-lived impact; any reaction should be small unless accompanied by other news.

Evidence & confidence

The filing provides a concrete buy datapoint (size and date) but no new operational, financial, or deal information; also no 10b5-1 plan is cited.

Market effects

Minimal; this is company-specific insider activity with no sector-wide policy or competitive signal.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine or driven by personal liquidity/tax planning; without broader fundamentals, follow-through may not materialize.

Key entities

  • Alignment Healthcare, Inc.

    Subject of the insider transaction filing (ALHC).

  • Kent Mark

    President - MSO who reported an open-market purchase of ALHC shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.